Johnson & Johnson (J&J) reported $22.52 billion in fourth-quarter sales, exceeding Wall Street estimates by 5.3%, driven by a 19% global rise in cance...
Johnson & Johnson (J&J) reported $22.52 billion in fourth-quarter sales, exceeding Wall Street estimates by 5.3%, driven by a 19% global rise in cance...